New Funding Of Treatment Will Help Many Of The Over 300 New Zealanders Diagnosed With Liver Cancer Each Year
New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...
casereports.bmj4d
Pulmonary artery stenting for palliative treatment of refractory hypoxaemia in a patient with small cell lung cancer
Pulmonary artery stenosis (PAS) is most encountered in the paediatric population as a congenital anomaly. In adults, PAS from extrinsic compression of the pulmonary artery (PA) results from conditions ...
Cancer Research3d
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High–Risk Non–Muscle-Invasive Bladder Cancer
1Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. 2Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical ...
rmdopen.bmj5d
Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities
Ipilimumab, targeting CTLA-4, nivolumab and pembrolizumab, targeting PD-1, and atezolizumab, targeting PD-L1, are FDA-approved, with the first three drugs also approved in the European Union. ICIs ...